Lugano, April 15, 2025 – Swisseutic is pleased to announce a strategic distribution partnership with Qinghai Lake Pharmaceutical Co., Ltd. (QHL), a globally renowned leader in the manufacturing of licorice derivatives.
Founded in 1987 in the Qinghai region of the Tibetan Plateau, QHL is one of the most ancient and established manufacturers of licorice derivatives worldwide. The company specializes in high-quality licorice-based ingredients, including Ammonium Glycyrrhizinate (also known as MAG or Monoammonium Glycyrrhizinate), Dipotassium Glycyrrhizinate, Enoxolone (Glycyrrhetinic Acid), Glycyrrhizic Acid and purified licorice extracts such as Glabridin and Licochalcone A. These ingredients are widely used as food flavorings, pharmaceutical excipients, and cosmetic actives, among other applications.
Swisseutic, based in Lugano, Switzerland, is a company specializing in the distribution of natural ingredients. Founded by Christian Artaria, an industry expert with extensive experience, Swisseutic has quickly established itself as a trusted partner for high-quality ingredients in the pharmaceutical, food, nutraceutical, and cosmetic sectors.
Christian Artaria, Founder and President of Swisseutic, expressed his enthusiasm for the partnership: Christian Artaria, Founder and President of Swisseutic, expressed his enthusiasm for the partnership: “We are honored to represent QHL in Europe, a company that shares our commitment to excellence. This partnership perfectly aligns with Swisseutic’s mission, which is to select and supply the highest-quality natural ingredients, capable of meeting the most rigorous quality standards, in order to best support our European clientele across a wide range of sectors, including pharmaceuticals, nutraceuticals, cosmetics, and food.”
Through this collaboration, Swisseutic strengthens its portfolio by bringing QHL’s premium licorice derivatives to the European market, further reinforcing its position as a reliable partner in the pharmaceutical, food, and cosmetic industries.
Oliver Luo, CEO of QHL, shared his satisfaction with the partnership: “We are delighted to collaborate with Christian and the Swisseutic team. This partnership will allow us to expand our presence in Europe and better serve our customers with high-quality licorice derivatives.”
This collaboration marks an important step forward for both companies, combining QHL’s deep expertise in licorice derivatives with Swisseutic’s robust distribution network and market knowledge. Together, Swisseutic and QHL are committed to fully unlocking the potential of licorice by promoting its excellence and expanding its applications across the nutraceutical, pharmaceutical, food, and cosmetic industries throughout Europe.
*** ***
About Qinghai Lake Pharmaceutical Co., Ltd. (QHL)
Founded in 1987, Qinghai Lake Pharmaceutical Co., Ltd. (QHL) is a leading manufacturer of licorice derivatives. With a team of 80 employees, the company is located in the Qinghai region of the Tibetan Plateau, at an altitude of 2,800 meters, near Qinghai Lake – the largest lake in China, renowned for its alkaline waters.
QHL holds a pharmaceutical license and is ISO 9001 certified. Its sister company, Qinghai Blicsweet Licorice Technology Development Co., Ltd., holds a food license and is certified ISO 9001, ISO 22000, FSSC 22000, ISO 27001, ISO 45001, HACCP, Sedex and Cybervadis.
The company has successfully obtained CEP certification for its Ammonium glycyrrhizinate and holds a REACH certificate for Enoxolone and Dipotassium glycyrrhizinate. Additionally, all its licorice derivatives used in cosmetics are COSMOS-approved, CSAR registered and all products are certified vegan by The Vegan Society, OU Kosher and Halal.
Further Information on Qinghai Lake Pharmaceutical Co., Ltd.: www.qhlpharma.cn
About Swisseutic
Swisseutic SA specializes in supplying premium ingredients to the nutraceutical, pharmaceutical, food, feed, and cosmetic industries.
Swisseutic is built upon 25 years of expertise in the development, production, clinical validation, registration, and marketing of natural products. This wealth of knowledge extends across plant-based preparations (botanicals), encompassing highly purified products obtained directly from plants, as well as those produced through chemical or enzymatic modifications, fermentation technologies, or innovative processes such as production through photobioreactors. Swisseutic objective extends beyond being the primary distributor of botanical extracts; we aspire to be a trusted partner, adept at addressing any concerns related to the quality or availability of these products through a personalized and responsive service.
Further Information on Swisseutic: www.swisseutic.com
*** ***